Member Info for cornishpixie

funny, I've been thinking of doing the same today - regretting selling a few ITM start of this week anticipting a pull back

just bought some more on (what I hope was) the dip.
Reactions to RNS always unpredictable, but I think this is more likely to rise significantly over the next few days or weeks than it is to drop significantly

No
Any offer has to be approved by shareholders (there are various rules about this), and the process takes time.
There can also be the possibility of a (higher) counter bid - see Codemasters for a recent example
£3 is optimistic but we can dream. The current SP doesn't reflect such a belief in the wider market

@JM - you're probably right but not much we can do about it other than suck it up and realise we play by different rules.
Patience usually pays off.
Re RNS - not sure what to make of it - on the face of it promising, but equally could just be something they have put out to calm nerves / encourage bidders. Any deal may still be weeks or months away, or could drop by the end of this month.
Not de-ramping - still holding here and may add some more today at these prices

me too; don't know which way it going to go today, probably up, but longer term sure it will rise

Who knows: balancing their portfolio as the share rises - limits profits and losses - that's why we're not invested in funds, isn't it?

profit making and debt free? More than can be said for much of my portfolio which nevertheless seems to be doing ok.
There are so many things that go into assessing the value of a company, and the market traditionally looks forward to potential.
I can't see the relevance of number of staff members personally.
Nothing wrong with asking the question about share price value - aren't these discussion boards after all?
Clearly, the value of ARB is heavily dependent on the price of bitcoin. No-one truly knows which that is going, but smart money seems to be taking more of an interest.
I wouldn't go all in on ARB, but have a few in my portfolio, mostly at a cheaper price, and am holding on for now: potential for upside exceeds downside for me, but it is not risk free.

It's an expensive trial. ALso need to ensure patient groups in treatment and placebo arm are comparable. A good starting point is confirmed Covid rather than just suggestive symptoms.
Good luck whichever way it goes.
Once again, can I encourage shareholders to contact their local CCG (clinical commissioning groups - ie those in charge of healthcare in each region) and tell them about the home trial as I don't think it has been well publicised. It may be that SNG have deliberately kept it low key as they only have sufficient staff to deal with a certain number of patients / week.

I just don't think this trial is well publicised - in my area no-one in the health service seems aware, despite the fact that we (and presumably every other part of the country) have created Virtual Covid wards for clinically vulnerable patients with Covid - most of whom would fit the criteria for the trial.
I have informed our local team about the trial but due to my financial interest in Synairgen cannot be actively involved.
I've also written to Synairgen.
We shouldn't be relying on shareholders signing themselves and family up to this trial.
Can I suggest that others reading this inform their local CCG of the existence of the trial, drawing attention to the fact that the drug is also in phase 3 hospital trials in the UK and abroad; results of phase 2 trial; coverage on BBC today, etc

Overbought upto 3p+, almost inevitable retrace - the brave would have sold then and bought back in now, as some did. I didn't - too confident that a further rise will come over this year, and my holding is large (for me), having acquired when much cheaper. If I sold and then it rose, I wouldn't be able to buy back what I had sold.
If you can afford to wait, seems likely to rise significantly through the year, loads in the pipeline, the legal action may affect share price in short term but unlikely to be significant longer term, but nothing is certain. GLA DYOR

Maybe I'm being unduly optimistic, or seeing what I want to see, but rising profits and a shift towards profitability sounds promising to me.
There seem to be loads of companies on AIM with increasing mcaps who are a long way from profitability.
This market values promise as much as current performance.

HL aint the cheapest, but I've found them the best of the ones I've used to buy and sell on - wide range of stocks including N America, great app, most likely to get a quote when market is going mental. No problem recently buying ARB on them and AJBell. Not tried selling ;.>
I suspect that it is swings and roundabouts - those with cheap fees make it on the spread.
And missing a trade costs most of all.

Depends on your risk reward tolerance - if you're heavily in EUA then I'm guessing you are willing for higher risk in return for higher reward. I'd split it amongst a few options, but that's my way.
I'm in all the following (out of others):

Anything blockchain related is going mental at present - if you think it isn't too late then ARB, TRD
green energy: EQT dipped recently - over this year I reckon it will multibag some more
One of the rare earth miners - especially on a dip
SNG - if trials successful then licence to print money; if not then expect a large fall
Helium 1
Just took a small punt on KAT
Maestrano (MNO)
4D
SYME - seems reasonable chance of taking off, possiblity it's all smoke and mirrors

If I do well enough out of EQT perhaps I'll finally be able to afford one

With hindsight, selling at 3 and buying back in now (or later if it drops further) would have been a good call.
Whether selling at 2.4 and waiting for a drop will work only time will tell but good luck. I'm not willing to risk enough of my holding to make that worthwhile as I am confident in the meedium-long term this will continue to rise and that will bring me plenty of reward. Short to medium, none of us know - many factors could cause price swings; the court case although almost certainly spurious could still spoook the markets, warrants may have an effect, a positive RNS would boost SP. I suspect it will drop a little more from here: the rise has been so rapid past month or so that a retrace is not unlikely, and some will take their profits now; but calling the bottom is never easy.
I agree all investment is a gamble - even sticking your money under the bed

agreed, nothing wrong with being a day trader, but not sure why you would think anyone else wants to read about your daily trades?
And if you bought at 40 and had held you would now be 100% up, so not even much to boast about
each to their own however

I just bought some, no problem.

@Justice2u - no we're working with university of Sheffield: it shows there are lots of people working on developing tests.
You have only to look at GDR, ODX, Avacta, etc to see those that have been promising jam tomorrow for months.
Ours is just one of many, and successful development isn't certain - but I'm hopeful, and worth investing at these levels

@Jayman1 - why do you think it will drop tomorrow?
Overbought or another reason?
Seems likely to me that other posters likely to be correct suggesting that once people receive their dividend they will buy more

This would be such good news. Right now I'm staring at a box of Innova tests given to me from work even though we know that for every 20 tests on well people, one of them will be falsely positive, requiring that person (and family) to isolate until a more accurate PCR test. With a prevalence of 5/1000, the likelihood that a positive tests means that you have Covid is less than 2%. Just about acceptable as a quick screening tool if the false negative rate was good, but it fails to pick up nearly half the people who actually have Covid.
I can't wait until Avacta, ODX (both of whom I'm in), or failing that someone else, gets a reliable test that is actually useful in the real world. I'm guessing that isn't as easy as we thought (and as we were led to believe in the summer) - but, just maybe, it is now around the corner. I don't believe the guys at Avacta have been sitting on their hands for the past 6 months.